Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.
21 juin 2018 08h00 HE
|
Onconova Therapeutics, Inc.
New Role as the President involves leadership of the entire product portfolioPromotion reflects progress of Rigosertib to key data milestones NEWTOWN, Pa., June 21, 2018 (GLOBE NEWSWIRE) --...
Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association
07 juin 2018 08h30 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018
03 mai 2018 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2017 Financial Results
15 août 2017 07h00 HE
|
Onconova Therapeutics
NEWTOWN, Pa., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics Announces Closing of Public Offering of Common Stock
26 avr. 2017 17h25 HE
|
Onconova Therapeutics
NEWTOWN, Pa., April 26, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug...
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial Results
16 mars 2017 08h30 HE
|
Onconova Therapeutics
NEWTOWN, Pa., March 16, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel small...